Dose‐response and dose‐survival advantage for high versus low‐dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study
暂无分享,去创建一个
E. Gehan | S. Jones | A. Lobuglio | J. Costanzi | S. Rivkin | G. Cummings | R. Stephens | M. Samson | Albert F. Lobuglio | Edmund A. Gehan | Saul E. Rivkin